Jakafi 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQWE2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,586
Award facts
- Contract value 100% obligated
- $49,586.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $49,586.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through full and open competition. The contract is funded by the Defense Logistics Agency and performed at the contractor's Park Ridge location. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with registered small business status since 2001.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition strategy designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription medications, biologics, and medical consumables. Through this framework, DMS Pharmaceutical Group serves as a regional prime vendor contractor supporting global military healthcare operations across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DR26FQWE2?
SPE2DR26FQWE2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FQWE2 worth?
The government has obligated $49,586 on SPE2DR26FQWE2.
Is contract SPE2DR26FQWE2 an order under another contract?
Yes. SPE2DR26FQWE2 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWE2 competed?
The extent of competition for SPE2DR26FQWE2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award